PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in PharmaCyte Biotech, Inc..

News

PharmaCyte Biotech (NASDAQ:PMCB) Stock Price Down 0.5%

Ticker Report Shares of PharmaCyte Biotech, Inc. (NASDAQ:PMCB - Get Free Report) dropped 0.5% on Friday . The stock traded as low as $1.86 and last traded at $1.87. Approximately 5,910 shares traded hands during...\n more…

PharmaCyte Biotech announces $7 million strategic investment in MYMD

Seeking Alpha - Healthcare PharmaCyte Biotech announces $7 million strategic investment in MYMD...\n more…

MyMD Pharmaceuticals secures $7M investment from PharmaCyte Biotech

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Business Wire PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (MyMD) a clinical stage biopharmaceutical...\n more…

PharmaCyte Biotech (NASDAQ:PMCB) Trading Down 1.6%

Zolmax PharmaCyte Biotech, Inc. (NASDAQ:PMCB Get Free Report)s stock price dropped 1.6% during mid-day trading on Tuesday . The stock traded as low as $2.34 and last traded at $2.44...\n more…

PharmaCyte Biotech (NASDAQ:PMCB) Is In A Strong Position To Grow Its Business

Simply Wall St Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...\n more…